Year: 2021
Type: article
Abstract: Very long chain fatty acids (VLCFAs) are essential building blocks for synthesis of the ceramides and sphingolipids required for nerve, skin and retina function and 3-keto acyl-CoA synthases (ELOVL elongases) perform the first step in the FA elongation cycle. Although ELOVLs are implicated in common diseases including insulin resistance, hepatic steatosis and Parkinson’s, their underlying molecular mechanisms are unknown. Here we report the structure of the human ELOVL7 elongase, which includes an inverted transmembrane barrel structure surrounding a 35 Å long tunnel containing a covalently-attached product analogue. The structure reveals the substrate binding sites in the tunnel and an active site deep in the membrane including the canonical ELOVL HxxHH sequence. This indicates a ping-pong mechanism for catalysis, involving unexpected covalent histidine adducts. The unusual substrate-binding arrangement and chemistry suggest mechanisms for selective ELOVL inhibition, relevant for diseases where VLCFAs accumulate such as X-linked adrenoleukodystrophy.
Language: English
Subfield: Biochemistry
Domain: Life Sciences
Open Access status: green
Funders: Pfizer, Genome Canada, Merck KGaA, Wellcome Trust, Diamond Light Source, Ontario Ministry of Economic Development and Innovation, Fundação de Amparo à Pesquisa do Estado de São Paulo, Ministero dello Sviluppo Economico, Innovative Medicines Initiative, University of California, San Francisco, National Institute of General Medical Sciences
Awards: G1812239805, G1938887483, A UK Hub to Catalyse Open Target Discovery., G2592000683, G2939136323, Resource for Biocomputing Visualization and Informatics, Cellular Structural Biology, G4169075588, G4815039349, G4946031807, G5753071127, G6144682035, G6285642246, G6502606440, G7889860134, A laboratory for membrane protein structural biology, G8210555217, G8328638188
OpenAlex ID: W3103984707
